about
Sexual factors and prostate cancerCancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million AustraliansBody-Mass Index and Mortality among 1.46 Million White AdultsAssociation between adult height, genetic susceptibility and risk of gliomaRisk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countriesThe INTERPHONE study: design, epidemiological methods, and description of the study populationDetectable clonal mosaicism and its relationship to aging and cancerGenome-wide association study of glioma and meta-analysisFurther confirmation of germline glioma risk variant rs78378222 in TP53 and its implication in tumor tissues via integrative analysis of TCGA dataImputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33Characterization of large structural genetic mosaicism in human autosomeAnalysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer typesAfter BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedGenome-wide association studies identify four ER negative-specific breast cancer risk lociEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerAlcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studiesGenome-wide association study identifies novel breast cancer susceptibility lociThe androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriersNo evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancerThe AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian womenCYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndromeNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskDairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studiesFemale chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosomeAndrogenetic alopecia in men aged 40-69 years: prevalence and risk factorsELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancerGenome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphomaIron-overload-related disease in HFE hereditary hemochromatosisLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairMultiple newly identified loci associated with prostate cancer susceptibilityColorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular featuresFine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility lociCandidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer riskGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesGenetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSHormonal contraception increases risk of asthma among obese but decreases it among nonobese subjects: a prospective, population-based cohort studyRare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers
P50
Q21999082-6E045453-7712-4BB2-9A26-2022A5C6CD94Q22065627-548DF86A-C5F4-41A6-929B-CA81C2409784Q22250878-C65E069E-E59E-40DA-A989-F10E3C797643Q23910819-87D6A9B8-A698-47BE-BF34-1E0CBC3F5699Q23912277-62C97D04-467E-404A-9FC5-1812F02EEBD5Q23912478-0B84A556-081E-4A6C-9878-5635C108D8F8Q23916196-57275F7A-864D-480D-AC56-30595B943C3BQ23919638-6910CB45-8E04-467D-A5AF-9103726EBF62Q23924182-7A43CA99-AA38-4981-8BB2-EBC857834164Q23924183-7098B1EC-C911-40D2-8FE4-6C69D7999891Q24169697-13D8FBDC-F989-4142-840E-814E20B875EDQ24170413-D3D84E98-2894-4D63-8FF9-A714F27F0E2DQ24535695-4FC0AE60-45CB-4C93-A5EF-F70CF815D48FQ24610409-A6E44CCD-5641-4BE5-BD06-A3E361E88043Q24622610-914103B1-1A3B-4085-9937-74EFA942ED2BQ24633316-2E52DD97-21AC-4068-9368-41C9F309A60CQ24644568-6D56203C-2232-464F-B697-EBA7F49D3398Q24645441-A7487E0D-1108-45FC-ABF1-F9771111C81BQ24797305-5B045DD7-D493-4D24-A8D7-091A48AE8B78Q24800108-CE3EAA64-4AD2-4D0A-BAEA-FE998F308239Q24810265-53F432FF-8A94-4E11-A648-A75719EB7BE3Q24810733-6AFFF363-8DA3-4060-A39B-8F95AE6390F7Q26775022-18091116-8151-48BB-8159-43C1049476D4Q26799669-3A9C8F47-2FDF-44D5-8210-92C778D78E91Q26996384-94A3EE20-9E4F-40D3-852A-18BC95C47AACQ27908479-DC9B195A-065C-4107-8D51-115E19DB2CD1Q28191418-310B5DDC-DB18-461E-9403-FDD80726681CQ28208394-87F8464C-667B-4325-BDD2-8D147E4EED8EQ28248768-F9C70EC5-AA4B-458C-84D3-BBE6EFECD517Q28264901-8AACB17C-262E-4374-8287-409D9C69B1BCQ28267893-87EF3DBB-D550-4A5A-9366-60C7945B6D0BQ28268180-F83479AD-EF35-4858-BD85-BE79D3D8A37FQ28284149-91265027-7CEA-4265-ADFE-E3986AD0EC17Q28384269-D591109E-86B5-437F-A7B8-7607FB630A3BQ28385765-D2754F5C-06C8-4237-B00F-2AAB5C5D1995Q28388497-6C30BBC4-8C41-4F25-B23B-684F98D715C6Q28393571-E2D3AE3E-AE7A-43A8-87E5-78204863EA30Q28584533-AE3AC739-8146-4437-8397-9E1C3C1EFF18Q28596814-BE0BA9A7-CF2F-4DCE-86DA-99844863D9D3Q28652056-8FB73ADD-4152-410C-B920-D37209CBCBB5
P50
description
forsker
@nb
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究員
@ja
name
Graham G Giles
@nl
Graham G Giles
@sl
Graham G. Giles
@en
Graham G. Giles
@es
Graham G. Giles
@nb
Graham Giles
@fr
グレアム・G・ジャイルズ
@ja
type
label
Graham G Giles
@nl
Graham G Giles
@sl
Graham G. Giles
@en
Graham G. Giles
@es
Graham G. Giles
@nb
Graham Giles
@fr
グレアム・G・ジャイルズ
@ja
altLabel
Giles GG
@en
Graham G Giles
@en
Graham Giles
@en
Richard Kefford
@en
prefLabel
Graham G Giles
@nl
Graham G Giles
@sl
Graham G. Giles
@en
Graham G. Giles
@es
Graham G. Giles
@nb
Graham Giles
@fr
グレアム・G・ジャイルズ
@ja
P106
P1153
57193910834
P21
P31
P496
0000-0003-4946-9099